FLUXIL

This brand name is authorized in Albania, Cyprus, Hong Kong SAR China, Malta, Singapore.

Active ingredients

The drug FLUXIL contains one active pharmaceutical ingredient (API):

1	Fluoxetine UNII I9W7N6B1KJ - FLUOXETINE HYDROCHLORIDE
	Fluoxetine is a selective inhibitor of serotonin reuptake, and this probably accounts for the mechanism of action. Fluoxetine has practically no affinity to other receptors such as α1, α2, and β-adrenergic; serotonergic; dopaminergic; histaminergic1; muscarinic; and GABA receptors.
	Read more about Fluoxetine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FLUXIL Capsule	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AB03	Fluoxetine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	290/385
HK	Department of Health Drug Office	41520
MT	Medicines Authority	MA115/00901
SG	Health Sciences Authority	12576P